J1457 HCPCS Level II code: Injection, gallium nitrate, 1 mg
CMS terminated J1457: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J1457Injection, gallium nitrate, 1 mg
Short description: Gallium nitrate injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1457 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2005
- Terminated after
- Dec 31, 2025
Where J1457 sits
- 1J codesDrugs administered other than orally
- 2Terminated J1457Injection, gallium nitrate, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J1457 still valid?
No. CMS terminated J1457; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J1457?
CMS lists J1457’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1457
All J codesJ1451Injection, fomepizole, 15 mgJ1452Injection, fomivirsen sodium, intraocular, 1.65 mgJ1453Injection, fosaprepitant, 1 mgJ1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgJ1455Injection, foscarnet sodium, per 1000 mgJ1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mgJ1458Injection, galsulfase, 1 mgJ1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1460Injection, gamma globulin, intramuscular, 1 ccJ1551Injection, immune globulin (cutaquig), 100 mgJ1552Injection, immune globulin (alyglo), 500 mgJ1553Injection, immune globulin (yimmugo), 100 mg